These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8833054)

  • 1. Combination therapy in rheumatoid arthritis: the animal model perspective.
    Oliver SJ; Brahn E
    J Rheumatol Suppl; 1996 Mar; 44():56-60. PubMed ID: 8833054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Animal models of rheumatoid arthritis. Clues to etiology and treatment.
    Brahn E
    Clin Orthop Relat Res; 1991 Apr; (265):42-53. PubMed ID: 2009677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of animal models for identification of potential therapeutics for rheumatoid arthritis.
    Hegen M; Keith JC; Collins M; Nickerson-Nutter CL
    Ann Rheum Dis; 2008 Nov; 67(11):1505-15. PubMed ID: 18055474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of current strategies in the future treatment of rheumatoid arthritis.
    Weinblatt ME
    Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():19-23. PubMed ID: 10646485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and toxicity considerations in outcome directed therapy in rheumatoid arthritis.
    Fries JF
    J Rheumatol Suppl; 1996 Mar; 44():102-6. PubMed ID: 8833065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a need for new therapies for rheumatoid arthritis?
    Fleischmann RM
    J Rheumatol Suppl; 2005 Feb; 73():3-7; discussion 29-30. PubMed ID: 15693109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotrimoxazole treatment for rheumatoid arthritis.
    Rozin A; Schapira D; Braun-Moscovici Y; Nahir AM
    Semin Arthritis Rheum; 2001 Oct; 31(2):133-41. PubMed ID: 11590583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological management of early rheumatoid arthritis--does combination therapy improve outcomes?
    Dougados M; Smolen JS
    J Rheumatol Suppl; 2002 Nov; 66():20-6. PubMed ID: 12435165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy with cyclosporine in rheumatoid arthritis.
    Yocum DE
    J Rheumatol Suppl; 1996 Mar; 44():75-7. PubMed ID: 8833059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) study.
    Gibofsky A; Palmer WR; Goldman JA; Lautzenheiser RL; Markenson JA; Weaver A; Schiff MH; Keystone EC; Paulus HE; Harrison MJ; Whitmore JB; Leff JA
    Curr Med Res Opin; 2006 Jan; 22(1):169-83. PubMed ID: 16393443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
    Hyrich KL; Watson KD; Silman AJ; Symmons DP;
    Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment strategies in early rheumatoid arthritis.
    Suresh E; Lambert CM
    Ann Rheum Dis; 2005 Sep; 64(9):1252-6. PubMed ID: 15860511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies in rheumatoid arthritis over a 40-year period.
    Kremers HM; Nicola P; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2004 Dec; 31(12):2366-73. PubMed ID: 15570636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rheumatoid arthritis in the 21st century: targeting B-lymphocytes.
    Brezinschek HP; Brickmann K; Yazdani-Biuki B; Dörner T; Graninger WB; Brezinschek RI
    Wien Med Wochenschr; 2006 Jan; 156(1-2):61-7. PubMed ID: 16465615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in rheumatoid arthritis therapy.
    Kim-Howard XR; Staudt L; James JA
    J Okla State Med Assoc; 2005 Feb; 98(2):53-62. PubMed ID: 15789642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.